- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Dermatology Research and Practice
Volume 2012 (2012), Article ID 303275, 6 pages
Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
Dermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, Mexico
Received 1 December 2011; Revised 30 January 2012; Accepted 31 January 2012
Academic Editor: Iris Zalaudek
Copyright © 2012 Berenice Moreno-Cruz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Y. T. Jadotte and C. K. Janniger, “Pityriasis alba revisited: perspectives on an enigmatic disorder of childhood,” Cutis, vol. 87, no. 2, pp. 66–72, 2011.
- M. B. Weber, L. G. S. de Ávila, R. Albaneze, O. L. M. de Oliveira, B. D. Sudhaus, and T. F. Cestari, “Pityriasis alba: a study of pathogenic factors,” Journal of the European Academy of Dermatology and Venereology, vol. 16, no. 5, pp. 463–468, 2002.
- F. Vargas-Ocampo, “Pityriasis alba: a histologic study,” International Journal of Dermatology, vol. 32, no. 12, pp. 870–873, 1993.
- R. F. Martín, A. Lugo-Somolinos, and J. L. Sánchez, “Clinicopathologic study on pityriasis alba,” Boletin de la Asociacion Medica de Puerto Rico, vol. 82, no. 10, pp. 463–465, 1990.
- V. di Lernia and C. Ricci, “Progressive and extensive hypomelanosis and extensive pityriasis alba: same disease, different names?” Journal of the European Academy of Dermatology and Venereology, vol. 19, no. 3, pp. 370–372, 2005.
- R. Ruiz-Maldonado, “Hypomelanotic Conditions of the Newborn and Infant,” Dermatologic Clinics, vol. 25, no. 3, pp. 373–382, 2007.
- E. Galadari, M. Helmy, and M. Ahmed, “Trace elements in serum of pityriasis alba patients ,” International Journal of Dermatology, vol. 31, no. 7, pp. 525–526, 1992.
- M. J. Du Toit and H. F. Jordaan, “Pigmenting pityriasis alba,” Pediatric Dermatology, vol. 10, no. 1, pp. 1–5, 1993.
- S. Urano-Suehisa and H. Tagami, “Functional and morphological analysis of the horny layer of pityriasis alba,” Acta Dermato-Venereologica, vol. 65, no. 2, pp. 164–167, 1985.
- A. G. Ochoa and F. Vargas Ocampo, “Treatment pityriasis alba with a combination of coal tar, diiodohydroxyquinoline and hydrocortisone,” Medicina Cutanea Ibero-Latino-Americana, vol. 8, no. 1–3, pp. 69–72, 1980.
- D. Rigopoulos, S. Gregoriou, C. Charissi, G. Kontochristopoulos, D. Kalogeromitros, and S. Georgala, “Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study,” British Journal of Dermatology, vol. 155, no. 1, pp. 152–155, 2006.
- W. H. Fujita, C. L. Mccormick, and A. Parneix-spake, “An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba,” International Journal of Dermatology, vol. 46, no. 7, pp. 700–705, 2007.
- T. L. Clemens, J. S. Adams, and N. Horiuchi, “Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3,” Journal of Clinical Endocrinology and Metabolism, vol. 56, no. 4, pp. 824–830, 1983.
- E. L. Smith, N. C. Walworth, and M. F. Holick, “Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions,” Journal of Investigative Dermatology, vol. 86, no. 6, pp. 709–714, 1986.
- J. E. M. Körver, W. H. P. M. Vissers, D. W. A. Van Rens et al., “A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation,” British Journal of Dermatology, vol. 156, no. 1, pp. 130–137, 2007.
- J. Reichrath, A. Perez, S. M. Müller et al., “Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation,” Acta Dermato-Venereologica, vol. 77, no. 4, pp. 268–272, 1997.
- P. C. M. van de Kerkliof, “Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs,” Journal of Investigative Dermatology Symposium Proceedings, vol. 1, no. 1, pp. 78–81, 1996.
- Z. A. Abdel-Malek, R. Ross, L. Trinkle, V. Swope, J. W. Pike, and J. J. Nordlund, “Hormonal effects of vitamin D3 on epidermal melanocytes,” Journal of Cellular Physiology, vol. 136, no. 2, pp. 273–280, 1988.
- E. Rizova and M. Corroller, “Topical calcitriol - Studies on local tolerance and systemic safety,” British Journal of Dermatology, vol. 144, no. 58, pp. 3–10, 2001.
- V. Lepe, B. Moncada, J. P. Castanedo-Cazares, M. B. Torres-Alvarez, C. A. Ortiz, and A. B. Torres-Rubalcava, “A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo,” Archives of Dermatology, vol. 139, no. 5, pp. 581–585, 2003.
- H. Y. Kang and Y. M. Choi, “FK506 increases pigmentation and migration of human melanocytes,” British Journal of Dermatology, vol. 155, no. 5, pp. 1037–1040, 2006.
- H. Watabe, Y. Soma, Y. Kawa et al., “Differentiation of murine melanocyte precursors induced by 1,25-dihydroxyvitamin D3 is associated with the stimulation of endothelin B receptor expression,” Journal of Investigative Dermatology, vol. 119, no. 3, pp. 583–589, 2002.
- S. P. Hong, Y. Oh, M. Jung et al., “Topical calcitriol restores the impairment of epidermal permeability and antimicrobial barriers induced by corticosteroids,” British Journal of Dermatology, vol. 162, no. 6, pp. 1251–1260, 2010.
- N. Goksugur, B. Ozbostanci, and S. B. Goksugur, “Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba,” Pediatric Dermatology, vol. 24, no. 5, pp. E63–E65, 2007.
- M. Ambo, “Relapsing kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis,” Acta Dermato-Venereologica, vol. 82, no. 3, pp. 224–225, 2002.